Abstract
A case of multiple organ tuberculosis (TBc) involving lung, pleura, and peritoneum in a 39-year-old man with long-standing ankylosing spondylitis (AS) treated with adalimumab was presented. The relationship between antitumor necrosis factor-α (anti-TNF-α) therapy and TBc was also reviewed. This case illustrates that TBc can develop in multiple organs during adalimumab therapy, and thus, the awareness of serious complications of multiple organs and atypical extrapulmonary pattern of TBc during anti-TNF-α therapy needs to be increased.
| Original language | English |
|---|---|
| Pages (from-to) | 787-790 |
| Number of pages | 4 |
| Journal | Rheumatology International |
| Volume | 32 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2012.03 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adalimumab
- Ankylosing spondylitis
- Multi-organs
- Tuberculosis
Quacquarelli Symonds(QS) Subject Topics
- Medicine
- Biological Sciences
Fingerprint
Dive into the research topics of 'Multiple organ tuberculosis of lung, pleura, and peritoneum in ankylosing spondylitis during adalimumab therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver